Background: The objective was to collect characteristics of patients with male erectile disorder (MED) attending a male sexual dysfunction clinic and determine the level of psychological morbidity whilst recruiting subjects into a psychotherapy study. Methods: This was a study of data of 132 patients diagnosed as having male erectile disorder who attended a sexual problems assessment clinic. Men with a psychological component to their condition who accepted couple therapy were compared with those who refused such a treatment as well as with the group of men who were diagnosed as having an organic basis for their condition. All male attendees at the sexual dysfunction clinic over a ten month period were reviewed. The proportion of men with psychogenic factors contributing to the MED and who choose psychological therapy were noted as were demographic factors correlating with accepting therapy. Findings: Psychogenic factors were found to contribute towards the erectile disorder in the majority of cases. 28% of this group accepted couple psychotherapy in preference to a physical treatment. A signi®cant proportion of these couples had returned preliminary questionaries to the clinic and had attended the assessment together. A younger age of onset of the problem for the man; a younger age of his partner; a shorter duration of the relationship together and not being married were all associated with accepting couple psychotherapy in preference to other treatments. Conclusions: Psychogenic factors are contributory in a majority of cases of erectile dysfunction. Epidemiological factors are identi®ed in a group of men with MED. Where couple psychotherapy is indicated, certain factors are suggestive of patients who will accept such an option. Patient preference for a treatment option may play an important role in the outcome of therapy.
Introduction
Male erectile disorder (MED) may result from psychological, physiological or pharmacological causes or a combination of these. Anecdotal evidence suggests that the assessment of the sexual dysfunction and tendency to recommend or offer a particular treatment, will be in¯uenced by the clinic setting. There are few clinics which offer patients full medical, psychiatric and psychosexual history assessment, physical examination and appropriate investigation. Likewise, few clinics will offer the full range of treatment options although these are starting to become established. 1 For example, in a recent audit of a psychosexual assessment clinic for erectile dysfunction, 40% were seen once and discharged with educational advice regarding the use of a vacuum constriction device, 38% were entered into a multi-centred drug study, 4% referred to the urology service and only 18% offered psychosexual counselling. 2 Within those clinics offering psychotherapeutic options, the therapy may be offered to only the man whereas the evidence is that couples' issues are often pivotal. 3 To date, there remains a lack of consensus regarding which patients are best suited to which treatment options.
A new research assessment and diagnostic service was established with one of the aims being to collect characteristics of patients and establish the degree of psychological morbidity. A wide variety of treatment choices were made available to patients after a diagnosis was made. Patients were able to enter one of two studies where eligible. These were a course of brief couple therapy (C Th) or a multicentred pharmacological study. However, all appropriate treatment options were made available to patients without undue emphasis or prejudice. Essentially, patients eligible to either study were those diagnosed as suffering from psychogenic or combined aetiology MED. This paper describes the ®ndings.
Method

Recruitment of patients
Patients were referred mainly by general practitioners, psychiatrists and urologists but also from other physicians. They were posted information publicising the specialist clinic, which offered a full diagnostic and treatment service for patients with MED. The site was a single teaching hospital and the assessment clinic was within the established psychosexual clinic. A full assessment service was offered for male patients complaining of potency problems which included a full medical history, psychiatric evaluation and a detailed psychosexual history. All patients underwent a physical examination 4 and blood samples taken to establish full blood count, blood sugar, serum testosterone and prolactin. Where clinically indicated, further investigation using intra cavernous injection (ICI) of papaverine (or subsequently prostaglandin E1) within the clinic, and duplex ultrasonography and/or cavernosometry/carvenosogram were instigated. Referral on to an interested andrologist for a second opinion and management would occur at this stage.
All patients were mailed the GRIMS and GRISS questionnaire 5, 6 for both themselves and their partner to complete and return before their initial appointment. All partners were invited to attend with the patient, should he wish this to occur. Patients attending the clinic (held in the medical outpatient clinic) were also asked to complete the HAD 7 and the Pleasant/Unpleasant Sexual Feelings 8, 9 questionnaires. The partner was asked to complete the latter questionnaire if she was present.
The diagnosis was made primarily on the ®ndings described above. The presence of recognised medical conditions which are associated with MED (such as diabetes, hypertension, vascular disease) or the prescription of medications associated with impairing male sexual arousal led to a primary diagnosis of organic MED. Factors suggestive of a psychogenic origin include presence of morning or nocturnal erections, situational erections (with another partner or during masturbation) and an acute onset (in the absence of trauma). A diagnosis of combined aetiology MED was made where criteria were met for diagnosis (DSM III-R); there was presence of one or more psychological factors and the presence of organic factors was considered of minimal importance. The role of ICI in diagnosis remains controversial and was not conducted in most cases. At the time of the study nocturnal penile tumescence and rigidity (NPTR) monitoring was not available.
In all cases of psychogenic and combined MED a range of treatment options were presented to the patients in a standardised format. This included describing the options of individual psychotherapy (for which there was a waiting list), brief C Th, oral medication (either yohimbine or entry into a multicentre drug trial), vacuum constriction devices (VCD) (with demonstration available), intra cavernous injection (ICI) of papaverine (or subsequently alprostadil), or the option to attend the andrology clinic for a second opinion from a urologist. The option of referral to urology was emphasised predominantly for men where vascular disease warranted investigation for vascular surgery or penile prothesis implantation.
Analysis of the data
Demographic characteristics are reported with mean values and standard deviations. Unifactorial analysis was computed. Where there were categorical responses the observed frequencies were analysed for differences between groups using the Chi-Square test. The Mann Whitney U-test was used to look for differences in continuous variable measures between the group of men who consented to brief C Th and those that did not. For categorical variable measures the ChiSquare test with Yate's correction was used except where the minimum established expected value was low where the Fisher Exact Test (2 tail) was used.
A logistic regression model was applied to look at the choice of patient treatment and the referring agency; diagnosis made; age and duration of problem; and measures of both GRIMS and GRISS. The GRISS was subdivided into the impotence score and the total score less the impotence score.
Men who were diagnosed as having psychological or combined aetiology MED are shown as eligible patients for C Th and sub-divided into those who consented and those who did not. The ineligible group consist of the organic MED patients and men with other exclusion criteria. The outcome of those patients accepting C Th is described elsewhere. 10 
Results
Referrals to the clinic and diagnosis
One hundred and ninety-one patients were referred to the research clinic over a ten month period. The referral agencies are shown in Table 1 . The majority of patients seen in the clinic had been referred by their general practitioner. One hundred and thirtynine patients attended for assessment of whom 132 were diagnosed to have MED. Fourteen patients cancelled their appointment and 38 patients failed to attend their appointment. There was no evidence that men referred speci®cally to the study differed from those men referred with MED to the general psychosexual clinic.
The majority of cases were referred from their primary care physician, although 49 of the 132 (37.1%) men had received previous treatment for the dysfunction. Within each of the three groups described, there was no signi®cant difference in those previously receiving any form of treatment. Within the sample group, 17 went on to chose a second treatment from the clinic due to dissatisfaction or ineffectiveness of their chosen treatment. This sub-group is a smaller percentage (12.9%) than the initial cohort seeking a second or subsequent treatment. Of the 17 men, there was no signi®cant difference between the three diagnostic groups for these men (5 organic, 4 eligible refusers of C Th and 8 C Th) (Chi-square 5.09, P 0.08). Of the 17 men, 6 had previously had at least one previous treatment before referral to the clinic. Four had received sex therapy (1 was diagnosed as organic) and 2 a physical treatment (1 diagnosed as organic). Of the 37 couples entering C Th and the 55 eligible refusers there was no difference in the diagnosis between the two groups. (Yates corrected chi-square 2.23, P 0.14).
A psychogenic aetiology was considered the primary diagnosis in 80 (60.6%) of the cases and an organic aetiology in 26 (19.7%) of the cases. 26 (19.7%) cases were considered to have a combination of psychological and organic factors contributing to the MED.
Forty (30.3%) men had one or more exclusion factors that made them ineligible for C Th. Fifteen men were without a regular partner (of whom four also had an organic aetiology and one was out with the age range), this included two men who had established a relationship of under three months; 2 men were out with the age range (one also had no partner); 3 men had current major psychiatric illness (one also had an organic aetiology) and 26 were diagnosed as wholly organic cases of MED and so were excluded.
Ninety-two men (69.7%) were therefore eligible to be offered C Th and 37 (28%) men initially accepted this option. Considering speci®cally those 37 couples eligible and initially accepting C Th, 5 couples (13.5%) never commenced therapy and another 9 couples (24.3%) dropped out during therapy.
General demography
The demographic characteristics of the 132 patients diagnosed to have MED is shown in Table 2 . It distinguishes between men who were eligible for C Th-consenting (n 37), those men who were eligible for C Th-non consenting (n 55) and those men ineligible for C Th (n 40). Table 3 shows the socio-economic grouping for the 132 men. There was no evidence of signi®cant social class differences seen between the three groups described (P 0.22). Twelve of the 132 men were non Caucasian but there was no evidence that ethnic status differed between groups. A signi®cant difference was seen when comparing the number of men who were married in each group (P 0.04). 21 of the 40 (52.5%) men ineligible for C Th were married compared with 42 of the 55 (76.4%) men eligible for C Th-non consenting and 20 of the 37 (54.1%) men eligible for C Thconsenting. No differences were seen regarding loss of partner in the last two years (n 6). There were 119 men with a current partner and 44 of these men were accompanied by their partner. Signi®cant differences were seen between groups (P 0.006) with 21 of the 37 (56.8%) couples eligible for C Thconsenting attending together, 13 of the 55 (23.6%) couples eligible for C Th-non consenting and 10 of the 27 (37%) ineligible men being accompanied by their partner.
There was evidence of signi®cant differences in occurrence of medical illness between the groups (P 0.026) with this observed in 17 of the 40 (42.5%) ineligible men and 19 of the 92 (20.7%) eligible men. A similar signi®cant ®nding was seen for presence of current psychiatric illness (P 0.001) in 12 of the 40 (30%) ineligible man and only 4 of the 92 (4.3%) eligible men. No differences were found between groups for a history of a psychiatric illness in either the patient or his partner. Signi®-cant differences between groups were seen for current prescription of a pharmaceutical agent considered contributory to the MED (P 0.001) in 11 of the 40 (27.5%) ineligible men and 5 of the 92 (5.4%) eligible men.
Non signi®cant differences were seen between groups for intake of alcohol or cigarettes, history of sexual assault or presence of any other current sexual relationships.
A record of men returning the initial questionnaires before the assessment interview was only commenced in the second half of the study for 61 patients. A signi®cant difference was seen between groups (P 0.04) with 16 of the 19 (84.2%) eligible for C Th-consenting couples, 10 of the 21 (47.6%) eligible for C Th-non consenting couples and 11 of the 21 (52.4%) ineligible for C Th couples returning their questionnaires.
There were no differences seen between groups for a previous history of either sex therapy or a physical treatment for the MED. Seventeen of the 132 men had in the past received a course of sex therapy (4 were currently ineligible for such) and 32 had in the past been treated with some physical treatment for the MED.
Abnormal ®ndings on physical examination were observed in 7 of the 37 (18.9%) ineligible men and 3 of the 90 (3.3%) eligible men, this was a signi®cant ®nding between groups (P 0.005). Five men refused an examination. Table 4 shows the observed frequencies for the four factors considered relevant to making a diagnosis of a psychological contribution to the MED. There were signi®cant differences between groups with regard to presence of morning erections (P 0.0001), presence of masturbatory erections (P 0.006) and an abrupt onset of the MED (P 0.001) but not for erections in other situations (P 0.07).
There were signi®cant differences between the three groups concerning eligibility and acceptance of C Th and diagnosis with regard to aetiology for MED (P`0.0001) ( Table 5 ). However, no signi®cant difference was seen between those couples who were eligible for C Th consenting and those couples eligible for C Th-non consenting.
Choice of treatment
The treatment choice made by the patient is shown in Table 6 . Most patients who were ineligible for the C Th were also ineligible for the pharmaceutical study. The most popular choice after the two study treatments were intra cavernous injections with 21 men choosing this option.
Almost as many men (19) made a conscious decision to do nothing after the assessment interview. Four reported getting better, and two reported bene®t from reassurance that some factor could be identi®ed as a probable causal factor for the MED but chose to take no further treatment.
Seventeen of the men went on to make a second treatment choice after dissatisfaction with the ®rst choice for whatever reason. Of the ineligible group of men three went on to seek surgery and two tried a VCD. Of the men eligible for C Th-non consenting, two chose ICI, one chose to enter the drug study and I  5  8  9  22  II  7  16  13  36  III  13  18  9  40  IV and V  12  11  4  27  Other  3  2  2  7  All  40  55  37  132 Note: Other includes students and unemployed.
one requested an urology opinion. Of those eligible for C Th-consenting, eight went on to choose a second treatment. Six entered the drug study, one chose to use a penile ring and one requested individual therapy.
Demographic differences between men eligible for C Th-consenting and those eligible for C Th-non consenting where psychogenic or combined MED was diagnosed
There was some evidence for a signi®cant difference between the age of onset of men eligible for C Thnon consenters (mean 44.8 y) and men eligible for C Th-consenters (mean 38.7 y) (P 0.04) but not for the age at assessment (Table 2 ). A signi®cant difference was seen with regard to the age of the partner (P 0.001) (non-consenters mean age 46.5 y; consenters mean age 40.6 y). The length of the relationship showed signi®cant differences between groups (P 0.02) (non-consenters 18.6 y; consenters 10.2 y). A signi®cant difference was seen between the groups for marital status (P 0.04) with 42 of the 55 (76.4%) eligible for C Th-non consenters being married and 20 of the 37 (54.1%) eligible for C Thconsenters being married. Signi®cant differences 0  0  37  37  Individual therapy  3  2  0  5  Yohimbine  1  2  0  3  Drug study  1  24  0  25  GTN patches  0  0  0  0  Testosterone  1  0  0  0  Penile ring  0  0  0  0  Acupuncture  0  2  0  2  ICI  12  9  0  21  VCD  5  0  0  5  Urologist  4  0  0  4  Psychiatrist  4  0  0  4  Better  0  4  0  4  Reassured  2  0  0  2  Nothing  7  12  0  19  Total  40  55  37  132 were also noted between groups for returning their questionnaires before the assessment interview (P 0.04) (16 of the 19 (84.2%) consenters and 10 of the 21 (47.6%) non-consenters). Twenty-one of the 37 (56.8%) men eligible for C Th-consenters had their partner accompany them whilst 13 of the 52 (25%) men eligible for C Th-non consenters did which was a signi®cant difference (P 0.003).
Questionnaire scores
All of the 37 men eligible for C Th-consenters completed the GRIMS & GRISS and 36 of the partners completed these instruments. The total GRIMS marital state score is shown. The GRISS sexual satisfaction total score is shown as well as the impotence subscale score. Thirty-six of the men completed the HAD which consists of a depression and an anxiety scale. Thirty-six men and their partners also completed the pleasant/unpleasant questionnaire. There are two subscales which record pleasant and unpleasant feelings about particular sexual situations. Fifty of the men eligible for C Th-non consenters completed the GRIMS & GRISS and 32 of their partners completed these instruments. Of the ineligible for C Th group, 27 men and 18 partners completed the GRIMS and 33 men and 16 partners completed the GRISS. The scores from the questionnaires completed by men and their partners, and the normal range of scores are shown in Table 7 .
Discussion
The ®ndings presented in this paper allow consideration of the characteristics of a group of men whose primary diagnosis is MED. The proportion of cases considered to be exclusively psychogenic in origin is slightly higher than quoted elsewhere 4 but may re¯ect the initial opinion of the referrer as to the cause of the problem, including those directly referred from urology and psychiatric clinicians. Alternatively, it could be a correct assessment of psychogenicity.
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Previous reports from urology clinics have tended to report a greater proportion of wholly organic aetiology. 12±14 These authors acknowledge that the higher number of vasculogenic cases was probably accountable to the referral source accessing a tertiary urology clinic. In non specialised clinics the ability of non urologists (typically psychiatrists) assessing adequately the contribution of vasculogenic and arteriogenic factors in MED must be ascertained. Similarly, in urology clinics the ability of the clinician to assess adequately for psychogenic factors may be questioned as well as the tendency to inadvertently collude with patients seeking physical rather than psychological causation to endorse the use of physical treatment.
The majority of patients ful®lled the criteria to be eligible for one of the two investigational treatments offered. Of these men choosing psychotherapy (eligible for C Th-consenters) as their ®rst choice, it was encouraging that the majority decided on a couple approach rather than an individual approach to their problem. However, in the group choosing C Th, nearly half were cohabiting or in a long-standing non-marital relationship, and had been in their relationship with their partner for a shorter duration of time than those men eligible for C Th-non consenters who were more likely to be married and for twice the length of time of the C Th group. The consenting men and women were also likely to be younger in age. It may be argued that in the group eligible for C Th-non consenters there was a construct that marital behaviour had become too routine and entrenched with no expectation that change was possible. However, there is no evidence of increased marital/relationship dissatisfaction or con¯ict as re¯ected by the GRIMS questionnaire scores. Although it is dif®cult to make inference about the signi®cance from whether or not the partner attended the clinic, it is clear that the proportion was much higher in these going on to accept C Th. Was it that where couples came together they were more likely to be willing to consider attending for therapy for what was presented as a predominantly psychological problem than when the man attended himself? It may be suggested that when the man was unaccompanied he was either too embarrassed to inform his wife of the appointment, or the partner was embarrassed or not suf®ciently bothered by the problem to attend anyway. This is not to suggest that she was averse to becoming involved in treatment care if necessary, as many went on to participate in the pharmacological study where both partners had input (albeit minimal input by the woman). The majority of couples consenting to treatment returned their questionnaires prior to attending the assessment clinic. It may be argued that as the GRIMS and GRISS both ask questions of a highly personal nature, and that sending these may have dissuaded some women from both completing and attending the clinic. Despite this, no difference was seen between the eligible for C Th-non consenting and ineligible groups.
The value of the psychosexual history revealed three questions that were of value in reaching the diagnosis. The strongest factor of value in reaching the diagnosis of PMED was the presence of morning erections which is consistent with previous ®ndings. 4, 15, 16 Erections during masturbation and an abrupt onset of the problem were also highly likely to suggest PMED. Those men able to get erections in other situations (for example with another partner) were not found to be highly suggestive of PMED. It may be, that a sub-group of those men already noticing a problem of potency within their relationship as a consequence of medical illness, were testing out their potency in another situation rather than this group having`guilt from the affair' as the contributing factor towards their MED.
The choice of treatment was dominated by either C Th or medication in the eligible psychogenic/ combined MED group. The value of assessment in allowing some patients to`recover' needs further consideration. Despite the potential risks of entering a pharmacological study, it was not evident to the investigator that this factor was a major in¯uence on whether a man would choose an oral medication option or not, and only two chose yohimbine as an alternative.
For patients not choosing these two treatment choices, the most popular option was ICI rather than VCD. Although ICI appear to have more potential disadvantages, including a perceived painful procedure by the man, and a higher 6 and 12 month dropout rate compared with VCD, 17, 18 it had a higher initial take-up rate in both non-consenting and ineligible groups than a VCD. The latter do have a valuable role in treatment of MED, but it would appear the preference rates described elsewhere may re¯ect the presentation of speci®c treatments available to patients attending those speci®c clinics, or to the type of patient seen within a clinic, for example, diabetic patients. 19 As research continues into sex therapy for MED, the in¯uence of patient preference on outcome must be ascertained as well as controlling for potential bias of patients participating in sexuality research 20 and speci®c prognostic factors within any trial. 21 
